Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
Piper Jaffray analyst Joshua Schimmer came out with a research report on bluebird bio Inc (NASDAQ:BLUE) following an EHA conference where data was presented about HGB-205 which could …
Piper Jaffray analyst Joshua Schimmer weighed in today with his opinions on Uniqure NV (NASDAQ:QURE) after the company released its first quarter earnings and updated …
Piper Jaffray analyst Joshua Schimmer came out with a research report on ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) following the company’s encouraging update from the ongoing Phase …
In a research report issued today, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on bluebird bio Inc (NASDAQ:BLUE), and raised the …
Piper Jaffray analyst Joshua Schimmer weighed in today with a few insights on bluebird bio Inc (NASDAQ:BLUE), after the company announced that data from its ongoing Phase …
MannKind Corporation (NASDAQ:MNKD) reported first quarter 2015 results on May 7, revealing underwhelming sales and a mediocre Afrezza launch. Shares of MannKind last …
In a research report issued Friday, Piper Jaffray analyst Joshua Schimmer maintained a Neutral rating on MannKind Corporation (NASDAQ:MNKD) and reduced the price …
In a research report published May 6, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on bluebird bio Inc (NASDAQ:BLUE) with a price …
ISIS Pharmaceuticals, Inc. (NYSE:ISIS) has been reiterated as a Neutral at Piper Jaffray by research analyst Joshua Schimmer in a recent report released today.
